Through genomics and proteomics, researchers have linked the MSP-RON pathway with autoimmune diseases, such as IBD and PSC, but more research is needed to explore its pathogenesis and develop strategies for the treatment of IBD and PSC. This evidence concerns the gene MSMB and inflammatory bowel disease.